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What areas should new researchers in developingcountries choose in order to give relevantcontributions to medical knowledge?
Obviously the answer involves many different
subjects. It seems to us that presently molecular medicine
is very attractive. On the other hand, the applications of
discoveries in molecular medicine and new therapeutic
approaches require good clinical investigation methods,
and especially researchers trained as Clinical Trialists or
Clinical Epidemiologists. They are supposed to design
clinical trials, to consider the statistical power, conduct
research properly, etc.
When treatment results are moderate and the
prevalence of events is rare, higher numbers of patients
are needed in order to assess the new proposed treatment.
Unfortunately for the people and fortunately for the
researchers, developing countries have a large number of
complications as compared to the same diseases in
developed countries due to insufficient prevention
measures and insufficient early treatment. So, from this
point of view, research conducted in the poorer countries
may have a higher statistical power to detect treatment
differences when studying a lower number of cases, at
low costs as compared to the same research in the
developed countries. Indeed, some researchers in
developed countries consider countries like Brazil a
paradise for conducting research as long as there is an
association with researchers trained in clinical
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epidemiology. The same may be stated about the evaluation
of new predictive diagnostic tests, which will certainly
emerge from molecular medicine advances.
So young physicians who have finished a residence
program could be trained in Clinical Epidemiology, and
that could open the fields of clinical research and academic
careers for them.
There is no doubt that in the near future any medical
doctor in any specialty will need the knowledge of clinical
epidemiology to improve their critical appraisal skills, and
consequently, practice. Possibilities of giving relevant
professional contribution in developing countries would
be closer for medical doctors trained in Clinical
Epidemiology who are interested in an academic career.
In Brazil dozens of schools of medicine are expected to
commit themselves to evidence-based medicine and hire
these faculty members trained in Clinical Epidemiology
in order to improve their competitive edge in attaining
research grants. Also, the private health insurance groups
and government policy-makers need to reduce costs; the
methodology of critical appraisal of medical information,
and cost/benefit analysis are excellent tools to get more of
each dollar, particularly in the developing countries, where
the resources are scarce.
So, considering the universe of medical specialties,
it seems to us being valid suggesting to the MD newcomers
to consider Clinical Epidemiology as an interesting area
to learn and succeed professionally, thus improving the
health system of their countries (2, 3, 4, 5, 6).
The above statements may raise old polemics
between classical epidemiologists and clinical
epidemiologists (l).
However, our experience during the last decade is
that these two types of professionals may work together
positively in benefit of individuals and of the community.
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